APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Cancer Diagnostic Procedure

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastric Cancer Diagnostic Procedure Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 March 2026195 pages

Choose your research edition.

Industry ResearchGastric Cancer Diagnostic Procedure Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Cancer Diagnostic Procedure Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gastric Cancer Diagnostic Procedure Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Cancer Diagnostic Procedure Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Cancer Diagnostic Procedure Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Gastric Cancer Diagnostic Procedure market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastric Cancer Diagnostic Procedure include Pfizer Inc., Johnson & Johnson Co, F.Hoffmann La Roche, Merck & Co. Ilnc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, ThermoFisher Scientific Inc and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gastric Cancer Diagnostic Procedure market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastric Cancer Diagnostic Procedure and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastric Cancer Diagnostic Procedure revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gastric Cancer Diagnostic Procedure market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastric Cancer Diagnostic Procedure Segment by Company

Pfizer Inc.

Johnson & Johnson Co

F.Hoffmann La Roche

Merck & Co. Ilnc

Bayer AG

Novartis AG

Bristol-Myers Squibb Company

ThermoFisher Scientific Inc

AstraZeneca plc

Abbott Laboratories Inc

Sanof SA

Eli Lilly and Company

OtsukaPharmaceutical Co Ltd

AdventHealth, Atrium Health

Astellas Pharma Inc

Bausch Health Companies Inc

Gastric Cancer Diagnostic Procedure Segment by Type

Instrument

Test Strips and Consumables

Service

Gastric Cancer Diagnostic Procedure Segment by Application

Early Gastric Cancer

Advanced Gastric Cancer

Gastric Cancer Diagnostic Procedure Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Cancer Diagnostic Procedure market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Cancer Diagnostic Procedure and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Cancer Diagnostic Procedure.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gastric Cancer Diagnostic Procedure in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastric Cancer Diagnostic Procedure industry.

Chapter 3: Detailed analysis of Gastric Cancer Diagnostic Procedure companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastric Cancer Diagnostic Procedurerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Instrument Table 3. Key Players of Test Strips and Consumables Table 4. Key Players of Service Table 4. Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Early Gastric Cancer Table 6. Key Players of Advanced Gastric Cancer Table 7. Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Gastric Cancer Diagnostic Procedure Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Gastric Cancer Diagnostic Procedure Market Share by Region (2021-2026) Table 10. Global Gastric Cancer Diagnostic Procedure Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Gastric Cancer Diagnostic Procedure Market Share by Region (2027-2032) Table 12. Gastric Cancer Diagnostic Procedure Industry Trends Table 13. Gastric Cancer Diagnostic Procedure Industry Drivers Table 14. Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges Table 15. Gastric Cancer Diagnostic Procedure Industry Restraints Table 16. Global Gastric Cancer Diagnostic Procedure Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Company (2021-2026) Table 18. Global Gastric Cancer Diagnostic Procedure Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Gastric Cancer Diagnostic Procedure Key Company Head Office and Area Served Table 20. Global Gastric Cancer Diagnostic Procedure Company, Product Type & Application Table 21. Global Gastric Cancer Diagnostic Procedure Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Gastric Cancer Diagnostic Procedure by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Gastric Cancer Diagnostic Procedure Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Type (2021-2026) Table 28. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Type (2027-2032) Table 29. Global Gastric Cancer Diagnostic Procedure Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Application (2021-2026) Table 33. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Application (2027-2032) Table 34. Pfizer Inc. Company Information Table 35. Pfizer Inc. Business Overview Table 36. Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio Table 38. Pfizer Inc. Recent Development Table 39. Johnson & Johnson Co Company Information Table 40. Johnson & Johnson Co Business Overview Table 41. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio Table 43. Johnson & Johnson Co Recent Development Table 44. F.Hoffmann La Roche Company Information Table 45. F.Hoffmann La Roche Business Overview Table 46. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio Table 48. F.Hoffmann La Roche Recent Development Table 49. Merck & Co. Ilnc Company Information Table 50. Merck & Co. Ilnc Business Overview Table 51. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio Table 53. Merck & Co. Ilnc Recent Development Table 54. Bayer AG Company Information Table 55. Bayer AG Business Overview Table 56. Bayer AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 58. Bayer AG Recent Development Table 59. Novartis AG Company Information Table 60. Novartis AG Business Overview Table 61. Novartis AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 63. Novartis AG Recent Development Table 64. Bristol-Myers Squibb Company Company Information Table 65. Bristol-Myers Squibb Company Business Overview Table 66. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 68. Bristol-Myers Squibb Company Recent Development Table 69. ThermoFisher Scientific Inc Company Information Table 70. ThermoFisher Scientific Inc Business Overview Table 71. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 73. ThermoFisher Scientific Inc Recent Development Table 74. AstraZeneca plc Company Information Table 75. AstraZeneca plc Business Overview Table 76. AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio Table 78. AstraZeneca plc Recent Development Table 79. Abbott Laboratories Inc Company Information Table 80. Abbott Laboratories Inc Business Overview Table 81. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 83. Abbott Laboratories Inc Recent Development Table 84. Sanof SA Company Information Table 85. Sanof SA Business Overview Table 86. Sanof SA Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio Table 88. Sanof SA Recent Development Table 89. Eli Lilly and Company Company Information Table 90. Eli Lilly and Company Business Overview Table 91. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 93. Eli Lilly and Company Recent Development Table 94. OtsukaPharmaceutical Co Ltd Company Information Table 95. OtsukaPharmaceutical Co Ltd Business Overview Table 96. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio Table 98. OtsukaPharmaceutical Co Ltd Recent Development Table 99. AdventHealth, Atrium Health Company Information Table 100. AdventHealth, Atrium Health Business Overview Table 101. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio Table 103. AdventHealth, Atrium Health Recent Development Table 104. Astellas Pharma Inc Company Information Table 105. Astellas Pharma Inc Business Overview Table 106. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 108. Astellas Pharma Inc Recent Development Table 109. Bausch Health Companies Inc Company Information Table 110. Bausch Health Companies Inc Business Overview Table 111. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 113. Bausch Health Companies Inc Recent Development Table 114. North America Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) Table 120. North America Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032) Table 121. Europe Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) Table 127. Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032) Table 128. China Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 129. China Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 130. China Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 131. China Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) Table 138. Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Gastric Cancer Diagnostic Procedure Product Image Figure 2. Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gastric Cancer Diagnostic Procedure Market Share by Type: 2025 VS 2032 Figure 4. Instrument Image Figure 5. Test Strips and Consumables Image Figure 6. Service Image Figure 7. Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Gastric Cancer Diagnostic Procedure Market Share by Application: 2025 VS 2032 Figure 9. Early Gastric Cancer Image Figure 10. Advanced Gastric Cancer Image Figure 11. Global Gastric Cancer Diagnostic Procedure Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 13. Global Gastric Cancer Diagnostic Procedure Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Gastric Cancer Diagnostic Procedure Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Gastric Cancer Diagnostic Procedure Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Type (2021-2032) Figure 20. Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Application (2021-2032) Figure 22. North America Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 23. North America Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032) Figure 24. North America Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032) Figure 25. North America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 26. United States Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 27. Canada Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 29. Europe Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032) Figure 31. Europe Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032) Figure 32. Europe Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 33. Germany Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 34. France Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 36. Italy Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 37. Russia Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 39. China Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 40. China Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032) Figure 41. China Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032) Figure 42. Asia Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 43. Asia Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032) Figure 44. Asia Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032) Figure 45. Asia Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 46. Japan Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 50. India Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 51. Australia Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 56. Brazil Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 61. UAE Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 63. Chile Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument
  • Test Strips and Consumables
  • Service
Applications
  • Early Gastric Cancer
  • Advanced Gastric Cancer
Companies covered
  • Pfizer Inc.
  • Johnson & Johnson Co
  • F.Hoffmann La Roche
  • Merck & Co. Ilnc
  • Bayer AG
  • Novartis AG
  • Bristol-Myers Squibb Company
  • ThermoFisher Scientific Inc
  • AstraZeneca plc
  • Abbott Laboratories Inc
  • Sanof SA
  • Eli Lilly and Company
  • OtsukaPharmaceutical Co Ltd
  • AdventHealth, Atrium Health
  • Astellas Pharma Inc
  • Bausch Health Companies Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Instrument
  5. 1.2.3 Test Strips and Consumables
  6. 1.2.4 Service
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Gastric Cancer Diagnostic Procedure Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Early Gastric Cancer
  10. 1.3.3 Advanced Gastric Cancer
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Gastric Cancer Diagnostic Procedure Growth Trends by Region
  13. 1.5.1 Global Gastric Cancer Diagnostic Procedure Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Gastric Cancer Diagnostic Procedure Market Size by Region (2021-2026)
  15. 1.5.3 Gastric Cancer Diagnostic Procedure Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Gastric Cancer Diagnostic Procedure Market Dynamics
  1. 2.1 Gastric Cancer Diagnostic Procedure Industry Trends
  2. 2.2 Gastric Cancer Diagnostic Procedure Industry Drivers
  3. 2.3 Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges
  4. 2.4 Gastric Cancer Diagnostic Procedure Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gastric Cancer Diagnostic Procedure Revenue by Company (2021-2026)
  2. 3.2 Global Gastric Cancer Diagnostic Procedure Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gastric Cancer Diagnostic Procedure Key Company Head office and Area Served
  4. 3.4 Global Gastric Cancer Diagnostic Procedure Company, Product Type & Application
  5. 3.5 Global Gastric Cancer Diagnostic Procedure Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gastric Cancer Diagnostic Procedure Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gastric Cancer Diagnostic Procedure Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gastric Cancer Diagnostic Procedure Tier 1, Tier 2, and Tier 3
4 Gastric Cancer Diagnostic Procedure Market by Type
  1. 4.1 Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2032)
  3. 4.3 Global Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032)
5 Gastric Cancer Diagnostic Procedure Market by Application
  1. 5.1 Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2032)
  3. 5.3 Global Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer Inc.
  2. 6.1.1 Pfizer Inc. Company Information
  3. 6.1.2 Pfizer Inc. Business Overview
  4. 6.1.3 Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio
  6. 6.1.5 Pfizer Inc. Recent Developments
  7. 6.2 Johnson & Johnson Co
  8. 6.2.1 Johnson & Johnson Co Company Information
  9. 6.2.2 Johnson & Johnson Co Business Overview
  10. 6.2.3 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio
  12. 6.2.5 Johnson & Johnson Co Recent Developments
  13. 6.3 F.Hoffmann La Roche
  14. 6.3.1 F.Hoffmann La Roche Company Information
  15. 6.3.2 F.Hoffmann La Roche Business Overview
  16. 6.3.3 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio
  18. 6.3.5 F.Hoffmann La Roche Recent Developments
  19. 6.4 Merck & Co. Ilnc
  20. 6.4.1 Merck & Co. Ilnc Company Information
  21. 6.4.2 Merck & Co. Ilnc Business Overview
  22. 6.4.3 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio
  24. 6.4.5 Merck & Co. Ilnc Recent Developments
  25. 6.5 Bayer AG
  26. 6.5.1 Bayer AG Company Information
  27. 6.5.2 Bayer AG Business Overview
  28. 6.5.3 Bayer AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio
  30. 6.5.5 Bayer AG Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Bristol-Myers Squibb Company
  38. 6.7.1 Bristol-Myers Squibb Company Company Information
  39. 6.7.2 Bristol-Myers Squibb Company Business Overview
  40. 6.7.3 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 6.8 ThermoFisher Scientific Inc
  44. 6.8.1 ThermoFisher Scientific Inc Company Information
  45. 6.8.2 ThermoFisher Scientific Inc Business Overview
  46. 6.8.3 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  48. 6.8.5 ThermoFisher Scientific Inc Recent Developments
  49. 6.9 AstraZeneca plc
  50. 6.9.1 AstraZeneca plc Company Information
  51. 6.9.2 AstraZeneca plc Business Overview
  52. 6.9.3 AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio
  54. 6.9.5 AstraZeneca plc Recent Developments
  55. 6.10 Abbott Laboratories Inc
  56. 6.10.1 Abbott Laboratories Inc Company Information
  57. 6.10.2 Abbott Laboratories Inc Business Overview
  58. 6.10.3 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  60. 6.10.5 Abbott Laboratories Inc Recent Developments
  61. 6.11 Sanof SA
  62. 6.11.1 Sanof SA Company Information
  63. 6.11.2 Sanof SA Business Overview
  64. 6.11.3 Sanof SA Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio
  66. 6.11.5 Sanof SA Recent Developments
  67. 6.12 Eli Lilly and Company
  68. 6.12.1 Eli Lilly and Company Company Information
  69. 6.12.2 Eli Lilly and Company Business Overview
  70. 6.12.3 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio
  72. 6.12.5 Eli Lilly and Company Recent Developments
  73. 6.13 OtsukaPharmaceutical Co Ltd
  74. 6.13.1 OtsukaPharmaceutical Co Ltd Company Information
  75. 6.13.2 OtsukaPharmaceutical Co Ltd Business Overview
  76. 6.13.3 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio
  78. 6.13.5 OtsukaPharmaceutical Co Ltd Recent Developments
  79. 6.14 AdventHealth, Atrium Health
  80. 6.14.1 AdventHealth, Atrium Health Company Information
  81. 6.14.2 AdventHealth, Atrium Health Business Overview
  82. 6.14.3 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio
  84. 6.14.5 AdventHealth, Atrium Health Recent Developments
  85. 6.15 Astellas Pharma Inc
  86. 6.15.1 Astellas Pharma Inc Company Information
  87. 6.15.2 Astellas Pharma Inc Business Overview
  88. 6.15.3 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  90. 6.15.5 Astellas Pharma Inc Recent Developments
  91. 6.16 Bausch Health Companies Inc
  92. 6.16.1 Bausch Health Companies Inc Company Information
  93. 6.16.2 Bausch Health Companies Inc Business Overview
  94. 6.16.3 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  96. 6.16.5 Bausch Health Companies Inc Recent Developments
7 North America
  1. 7.1 North America Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  2. 7.2 North America Gastric Cancer Diagnostic Procedure Market Size by Type
  3. 7.2.1 North America Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026)
  4. 7.2.2 North America Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032)
  5. 7.2.3 North America Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032)
  6. 7.3 North America Gastric Cancer Diagnostic Procedure Market Size by Application
  7. 7.3.1 North America Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026)
  8. 7.3.2 North America Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032)
  9. 7.3.3 North America Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032)
  10. 7.4 North America Gastric Cancer Diagnostic Procedure Market Size by Country
  11. 7.4.1 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  13. 7.4.3 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
  14. 7.4.4 North America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  2. 8.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Type
  3. 8.2.1 Europe Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032)
  6. 8.3 Europe Gastric Cancer Diagnostic Procedure Market Size by Application
  7. 8.3.1 Europe Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032)
  10. 8.4 Europe Gastric Cancer Diagnostic Procedure Market Size by Country
  11. 8.4.1 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  2. 9.2 China Gastric Cancer Diagnostic Procedure Market Size by Type
  3. 9.2.1 China Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026)
  4. 9.2.2 China Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032)
  5. 9.2.3 China Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032)
  6. 9.3 China Gastric Cancer Diagnostic Procedure Market Size by Application
  7. 9.3.1 China Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026)
  8. 9.3.2 China Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032)
  9. 9.3.3 China Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  2. 10.2 Asia Gastric Cancer Diagnostic Procedure Market Size by Type
  3. 10.2.1 Asia Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032)
  6. 10.3 Asia Gastric Cancer Diagnostic Procedure Market Size by Application
  7. 10.3.1 Asia Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032)
  10. 10.4 Asia Gastric Cancer Diagnostic Procedure Market Size by Country
  11. 10.4.1 Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst